Health Assessment Study (0954-946)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

143 participants

Study Classification

INTERVENTIONAL

Study Start Date

2001-07-11

Study Completion Date

2003-01-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will look at the effects of losartan or atenolol on frequency of sexual intercourse in subjects with newly diagnosed mild to moderate hypertension.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)

NCT00338260

Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)

COMPLETED PHASE3

A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)

NCT01431508

Hypertension

COMPLETED PHASE4

A Study to Investigate the Antihypertensive Efficacy of MK0954

NCT00887250

Hypertension

COMPLETED PHASE3

A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)

NCT00886600

Hypertension

COMPLETED PHASE3

Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

NCT00140959

Hypertension

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MK0954, /Duration of Treatment : 16 Weeks

Intervention Type DRUG

Comparator : atenolol /Duration of Treatment : 16 Weeks

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newly diagnosed with mild to moderate hypertension\\
* Married male in stable heterosexual relationship
* No prior history of sexual dysfunction
* Satisfied with overall sex life
* Patient's spouse is in close proximity for the study
* Has had at least 2 but not more than 10 sexual intercourse events during the 2 week period prior to study start
* Patient able to visit doctor in the morning of each scheduled visit
* Able to complete the self administered health assessment questionnaire

Exclusion Criteria

* Hypertension due to cancer, history of heart or circulatory problems
* History of mental disorder that might impair sexual function
* History or presence of drug or alcohol abuse
* Prior surgery for erectile dysfunction or other urological procedure
* No penile implant or assist devices
* History of chronic liver disease, history of diabetes
* History of severe life-threatening diseases such as, cancer, AIDS or positive HIV test
* Subjects with only 1 kidney
* Mental handicap or legal incapacity

Minimum Eligible Age

40 Years

Maximum Eligible Age

49 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No